title: Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions.
abstract: Recently, we identified desmoglein 2 (DSG2) as the main receptor for a group of species B adenoviruses (Ads), including Ad3, a serotype that is widely distributed in the human population (H. Wang et al., Nat. Med. 17:96-104, 2011). In this study, we have attempted to delineate structural details of the Ad3 interaction with DSG2. For CAR- and CD46-interacting Ad serotypes, attachment to cells can be completely blocked by an excess of recombinant fiber knob protein, while soluble Ad3 fiber knob only inefficiently blocks Ad3 infection. We found that the DSG2-interacting domain(s) within Ad3 is formed by several fiber knob domains that have to be in the spatial constellation that is present in viral particles. Based on this finding, we generated a small recombinant, self-dimerizing protein containing the Ad3 fiber knob (Ad3-K/S/Kn). Ad3-K/S/Kn bound to DSG2 with high affinity and blocked Ad3 infection. We demonstrated by confocal immunofluorescence and transmission electron microscopy analyses that Ad3-K/S/Kn, through its binding to DSG2, triggered the transient opening of intercellular junctions in epithelial cells. The pretreatment of epithelial cells with Ad3-K/S/Kn resulted in increased access to receptors that are localized in or masked by epithelial junctions, e.g., CAR or Her2/neu. Ad3-K/S/Kn treatment released CAR from tight junctions and thus increased the transduction of epithelial cells by a serotype Ad5-based vector. Furthermore, the pretreatment of Her2/neu-positive breast cancer cells with Ad3-K/S/Kn increased the killing of cancer cells by the Her2/neu-targeting monoclonal antibody trastuzumab (Herceptin). This study widens our understanding of how Ads achieve high avidity to their receptors and the infection of epithelial tissue. The small recombinant protein Ad3-K/S/Kn has practical implications for the therapy of epithelial cancer and gene/drug delivery to normal epithelial tissues.
authors.affiliation: University of Washington, Division of Medical Genetics, Box 357720, Seattle, WA 98195, USA.
authors.forename: Hongjie
authors.initials: H
authors.lastname: Wang
authors.forename: ZongYi
authors.initials: Z
authors.lastname: Li
authors.forename: Roma
authors.initials: R
authors.lastname: Yumul
authors.forename: Stephanie
authors.initials: S
authors.lastname: Lara
authors.forename: Akseli
authors.initials: A
authors.lastname: Hemminki
authors.forename: Pascal
authors.initials: P
authors.lastname: Fender
authors.forename: André
authors.initials: A
authors.lastname: Lieber
mesh_terms: D000260:Adenoviruses, Human / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity; D036022:Capsid Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D051301:Desmoglein 2 / Q000378:metabolism*; D004847:Epithelial Cells; D006367:HeLa Cells; D006801:Humans; D007365:Intercellular Junctions; D011485:Protein Binding; D055503:Protein Multimerization; D017434:Protein Structure, Tertiary / Q000502:physiology*; D011991:Receptors, Virus / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D014161:Transduction, Genetic
chemical_list: D036022:Capsid Proteins; D051301:Desmoglein 2; D011991:Receptors, Virus; D011994:Recombinant Proteins; C085301:adenovirus receptor; C018315:hexon capsid protein, Adenovirus